Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia
Satoshi Yoshimura(St. Jude Children's Research Hospital), Jun J. Yang(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
|Nature Communications|2023|41
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
|Cancer Cell|2024|31
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia
|Nature Communications|2022|24
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
|bioRxiv (Cold Spring Harbor Laboratory)|2020|3